Springbok prop Asenathi Ntlabakanye has been handed an 18‑month ban after a doping tribunal found he had used prohibited substances. The Independent Doping Tribunal Panel, after two weeks of evidence and three weeks of deliberation, ruled that Ntlabakanye tested positive for the specified substance anastrozole and self‑reported use of the non‑specified drug dehydroepiandrosterone (DHEA). The sanction runs from 13 May 2026 and will expire on 13 November 2027, effectively ruling the player out of the 2027 Rugby World Cup.
The South African Institute for Drug‑Free Sport (SAIDS) released a statement confirming the ban and noting that the player, SAIDS, World Rugby and the World Anti‑Doping Agency (WADA) each have 21 days to lodge an appeal with the Court of Arbitration for Sport (CAS). If an appeal is filed, the outcome could alter the length of the suspension or the conditions of its enforcement.
Ntlabakanye has consistently maintained his innocence, asserting that the medication in question was prescribed by an endocrinologist and that he sought a second medical opinion before taking it. Despite the medical clearance he received, the tribunal concluded that the substances violated anti‑doping regulations, which are applied strictly regardless of therapeutic intent.
The ban carries significant financial implications. Estimates suggest Ntlabakanye could lose up to R5 million in earnings from his Springboks contract and related endorsements over the suspension period. The decision also removes a key front‑row option from the national squad ahead of the next World Cup cycle, forcing coaches to reshuffle the pack and consider alternative selections.
The case underscores the rigorous nature of anti‑doping enforcement in rugby and highlights the challenges athletes face when prescribed medication intersects with prohibited lists. It also serves as a reminder to governing bodies and players alike of the importance of thorough therapeutic use exemptions and proactive compliance checks.
All eyes will now turn to whether any of the parties involved will exercise the 21‑day appeal window. A successful challenge could see the ban reduced or lifted, while an upheld decision will cement Ntlabakanye’s absence from international competition for the next year and a half, reshaping South Africa’s forward options and influencing the broader conversation on doping policy in African sport.
